MOAT BIOTECHNOLOGY Corp — Form D

MOAT BIOTECHNOLOGY Corp of OKLAHOMA CITY, OK, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-20. The offering totals $15.6M, of which $26K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Todd P FoleyDirectorAlta, WY
Phillip P JonesDirectorNorman, OK
Michael P Moradi-AraghiDirectorOklahoma City, OK
Scott A RollinsDirectorOklahoma City, OK
Russell P RotherDirectorSteamboat Springs, CO
Scott A RollinsExecutive OfficerOklahoma City, OK
Russell P RotherExecutive OfficerSteamboat Springs, CO
Tetherex Pharmaceuticals P CorporationPromoterOklahoma City, OK
Scott A RollinsPromoterOklahoma City, OK
Russell P RotherPromoterSteamboat Springs, CO
Todd FoleyDirectorSouth San Francisco, CA
Philip A JonesDirectorOklahoma City, OK
Richard A AlvarezExecutive OfficerOklahoma City, OK
Tetherex Pharmaceuticals A CorporationPromoterOklahoma City, OK
Russell A RotherDirectorOklahoma City, OK
Russell A RotherExecutive OfficerOklahoma City, OK
Russell A RotherPromoterOklahoma City, OK
Todd A FoleyDirectorOklahoma City, OK
Philip JonesDirectorOklahoma City, OK
Tetherex Pharmaceuticals CorporationPromoterOklahoma City, OK
Richard AlvarezExecutive OfficerPhoenix, AZ
Scott RollinsDirectorOklahoma City, OK
Scott RollinsExecutive OfficerOklahoma City, OK
Scott RollinsPromoterOklahoma City, OK
Russell RotherDirectorOklahoma City, OK

Other filings by this issuer (3)

FiledFormOfferingSold
2023-02-09D$20.0M$102K
2022-10-11D/A$1.5M$1.5M
2022-09-21D$1.0M$1.0M

More